Select Page

Coxiron 60mg tablets

Ferron Par Pharmaceuticals

Product packaging may vary from one country to another.

Ingredients in every tablet

Etoricoxib 60 mg

Each package contains

3 blisters of 10 tablets

Other details

Dosage form:Tablet; coated
Flavour None

W.H.O. classification

ATC Level 1 M - Musculo-skeletal system
ATC Level 2 M01 - Antiinflammatory and Antirheumatic Products
ATC Level 3 M01A - Antiinflammatory and Antirheumatic Products; Non-Steroids

Warnings

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
Etoricoxib is given orally with or without food.

Arthritis (Osteoarthritis):
The recommended dose is 60 mg once daily.

Analgesia:
Acute pain associated with dental surgery:
The recommended dose is 120 mg once daily. Etoricoxib 120 mg should be used only for the acute symptomatic period.

Chronic musculoskeletal pain:
The recommended dose is 60 mg once daily

Doses greater than those recommended for each indication have either not demonstrated additional efficacy or have not been studied. Therefore, the dose for each indication is the maximum recommended dose.

Etoricoxib is administered orally. Etoricoxib may be taken with or without food.

ELDERLY PATIENTS
No dosage adjustment in etoricoxib is necessary for the elderly.

GENDER AND RACE
No dosage adjustment in etoricoxib is necessary based on gender or race.

PATIENTS WITH HEPATIC INSUFFICIENCY
— Mild hepatic insufficiency (Child-Pugh score 5-6):
A dose of 60 mg once daily should not be exceeded

— Moderate hepatic insufficiency (Child-Pugh score 7-9):
The dose should be reduced; a dose of 60 mg every other day should not be exceeded, administration of 30 mg once daily can also be considered.

— Severe hepatic insufficiency:
There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency (Child-Pugh score >9)

PATIENTS WITH RENAL INSUFFICIENCY
In patients with advanced renal disease (creatinine clearance <30 ml/min), treatment with etoricoxib is not recommended. No dosage adjustment is necessary for patients with lesser degrees of renal insufficiency (creatinine clearance ≥30 ml/min)

Indication

Etoricoxib is indicated for:
Symptomatic relief in the treatment of osteoarthritis (OA). (I p.1, II p.54, III p.1, IV p.1)
Relief of chronic musculoskeletal pain. (I, III p.1)
Relief of acute pain associated with dental surgery. (I, III p.1, IV p.1)